News and Updates

Discover stories from Breakthrough T1D about our research, advocacy, initiatives, and supporters.

The latest

Read the latest news from Breakthrough T1D.

Learn the basics about autoimmune disease, including prevalence in the U.S., possible causes, and why they are often called "invisible."

Breakthrough T1D Ride is more than cycling—it’s a movement to find cures for type 1 diabetes (T1D). No matter where you live, how you choose to ride, or how far you go, you’re surrounded by the T1D community—fellow riders, coaches, friends, and family—cheering you on at every milestone. A fully supported cycling experience, finish-line celebration, […]

One of our most promising avenues toward cures for type 1 diabetes (T1D) is cell therapies. Cell therapies replace destroyed beta cells with functional, insulin-producing cells to restore insulin therapy independence. Right now, there are nearly a dozen cell therapies in clinical testing—and OPF-310 is one of them. OPF-310 cells are derived from porcine (pig) […]

Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law, ensuring continued momentum toward better treatments, disease-modifying therapies, and cures. This legislation: These are huge wins for the T1D community […]

This article was written by Alecia Wesner (pictured above, right), a Participant Advisory Council (PAC) member, a Clinical Trial Education Volunteer, and long-time Breakthrough T1D supporter. Alecia’s story details her lived experiences with type 1 diabetes, participation in clinical trials, and her journey to joining the PAC. The views expressed by the author are her […]

Recent articles

Nearly 3 years after Breakthrough T1D joined forces with Civica, a non-profit pharmaceutical company, its first insulin is now available for purchase at pharmacies across the country. Check out our story from October that highlights the years of partnership between Civica and Breakthrough T1D that made today a reality. We worked with our partners at […]

You rode. We cheered you on. Together, we fueled type 1 diabetes breakthroughs! Read our wrap-up of the Breakthrough T1D Ride 2025 season.

What’s happening? Continuous ketone monitoring (CKM) is on its way. A new paper in The Lancet Diabetes & Endocrinology, titled “International expert recommendations on the application and utility of continuous ketone monitoring for people with diabetes,” was published by Breakthrough T1D and expert collaborators, spearheaded by our Chief Medical Officer, International, Thomas Danne, M.D., Ph.D. […]

How quickly a year goes by—and a lot has happened for type 1 diabetes (T1D) in 2025! In these last few weeks leading up to the new year, Breakthrough T1D would like to take a moment to reflect on how far we’ve come in the past 365 days. Read on for the greatest T1D accomplishments […]

Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.

Press releases

Read the latest press releases and statements from Breakthrough T1D.

View All

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.